Back Pain News and Research

Latest Back Pain News and Research

$Hyponatremia linked to high risk of fractures in elderly patients$

Hyponatremia linked to high risk of fractures in elderly patients

A common blood disorder, hyponatremia, may be a risk factor for fractures in elderly patients, new research presented at the European Congress of Endocrinology shows.

3 May 2011

OU-COM receives Osteopathic Heritage Foundation grant to address healthcare issues

The Osteopathic Heritage Foundations' $105 million award to Ohio University's College of Osteopathic Medicine represents the largest private donation ever given to a college or university in Ohio. This gift will be used to address some of the most pressing health care issues across the state and the nation - the impending shortage of primary care physicians and the diabetes epidemic.

2 May 2011

Health Canada approves Eli Lilly's Cymbalta for chronic low back pain treatment

Eli Lilly Canada announced today that Health Canada has approved Cymbalta for the management of chronic low back pain.

30 Apr 2011

Zimmer launches UniWallis Posterior Dynamic Stabilization System in Europe and Asia Pacific

Zimmer Holdings, Inc., a global leader in musculoskeletal care, today announced the launch of the next generation of its Wallis® Posterior Dynamic Stabilization System, the UniWallis™ System, in Europe and Asia Pacific. Since the debut of the Wallis System in 2000, feedback collected from surgeons revealed the need for a device that maintains all of the clinical advantages of the Wallis System, provides improved ease of use and offers a more anatomy-sparing procedure.

29 Apr 2011

Patients of orthopedists are more apt to undergo back surgery

When doctors own or lease MRI equipment, their patients are more likely to receive scans for low back pain. Patients of orthopedists are more apt to undergo back surgery as well, according to a study published online in Health Services Research.

26 Apr 2011

SI-BONE receives FDA approval for updated iFuse Implant System

SI-BONE, Inc., a medical device company that is pioneering the use of a minimally invasive surgical device to treat the sacroiliac joint announced the U.S. Food and Drug Administration approved a major modification to the existing product label.

26 Apr 2011

Physiotherapy Associates inaugurates new clinic in Grand Haven, MI

Physiotherapy Associates, the nation's foremost provider of outpatient rehabilitation services, recently opened a new physical therapy clinic in Grand Haven, MI.

22 Apr 2011

Acorda receives patent for AMPYRA tablets to improve walking in MS patients

Acorda Therapeutics, Inc. today announced that the United States Patent and Trademark Office has allowed U.S. Patent Application No. 11/010,828 entitled "Sustained Release Aminopyridine Composition."

20 Apr 2011

Patients with low back pain can benefit from immediate physiotherapy

Immediate treatment by a physiotherapist, bypassing a waiting list, can reduce problems with recurring low back pain, reveals a thesis from the University of Gothenburg, Sweden.

19 Apr 2011

Chicago doctor develops new non-surgical procedure to alleviate back pain

Dr. Jeff Winternheimer of the Illinois Back Institute has developed a revolutionary non-surgical procedure to alleviate back pain. Both professional athletes and everyday back and neck pain sufferers have been flocking to his four Chicago area clinics to see for themselves.

15 Apr 2011

Positive results from laquinimod Phase III ALLEGRO study in multiple sclerosis to be presented at AAN

Teva Pharmaceutical Industries Ltd. and Active Biotech announced today results from the two-year Phase III ALLEGRO study of laquinimod, an oral, once-daily, investigational immunomodulator for the treatment of relapsing forms of multiple sclerosis (MS). These data will be presented as late-breaking research at the Annual Meeting of the American Academy of Neurology (AAN).

12 Apr 2011

Top-line results from DURECT's ELADUR Phase II trial in chronic low back pain

DURECT Corporation announced today top-line results from a Phase II clinical trial in chronic low back pain for ELADUR, DURECT's proprietary investigational transdermal bupivacaine pain patch.

12 Apr 2011

Gilenya can reduce risk of disability progression in patients with RRMS

A new analysis demonstrated that Gilenya reduced the risk of disability progression in patients with relapsing-remitting multiple sclerosis, regardless of treatment history. This analysis of the phase III two-year FREEDOMS study is one of 11 abstracts on Gilenya being presented at the 63rd annual meeting of the American Academy of Neurology.

11 Apr 2011

Alexion submits Soliris marketing applications to FDA, EMA for aHUS treatment

Alexion Pharmaceuticals, Inc. announced today that the company has submitted marketing applications to the U.S. Food and Drug Administration and the European Medicines Agency for Soliris as a treatment for patients with atypical Hemolytic Uremic Syndrome.

7 Apr 2011

Teenagers with scoliosis can benefit from new generation spine implants

Teenagers who undergo spine fusion for scoliosis using the newest surgical techniques can expect to be doing well 10 years after surgery, according to a Hospital for Special Surgery study published online ahead of print in the TK issue of the journal Spine.

6 Apr 2011

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced results from several new data analyses from the pivotal Phase III studies evaluating the addition of its investigational oral protease inhibitor VICTRELIS to peginterferon alfa-2b and ribavirin in adult patients with chronic hepatitis C virus genotype 1 infection.

1 Apr 2011

Important updates on spondyloarthritis highlighted at 2010 SPARTAN meeting

Spondyloarthritis is a group of inflammatory conditions causing spine and joint pain and deformity, mostly in young men. Important updates on the epidemiology, diagnosis, and treatment of SpA are presented in the April issue of The American Journal of the Medical Sciences, official journal of the Southern Society for Clinical Investigation.

31 Mar 2011

Pregnant women can benefit from low-to-moderate intensity weight-training program

Despite decades of doctors' reluctance to recommend weight training to pregnant women, a new University of Georgia study has found that a supervised, low-to-moderate intensity program is safe and beneficial.

28 Mar 2011

Purdue demonstrates efficacy of Butrans transdermal delivery system for chronic pain in opioid-naive patients

Physicians from Purdue Pharma LP, Stamford, CT, showcased study results that demonstrate the analgesic efficacy and safety of Butrans for the relief of moderate to severe chronic low back pain in opioid-naive patients. Butrans is a transdermal delivery system that provides systemic delivery of buprenorphine, a Schedule III medication, continuously over a 7-day period.

25 Mar 2011

Patients with low back pain can benefit from new spinal neuromodulation device

Results from an ongoing prospective study report that a novel spinal neuromodulation device changes the paradigm for patients suffering with low back pain who have not found relief through conventional spinal cord stimulation.

25 Mar 2011

Back Pain News and Research

Latest Back Pain News and Research

Hyponatremia linked to high risk of fractures in elderly patients

OU-COM receives Osteopathic Heritage Foundation grant to address healthcare issues

Health Canada approves Eli Lilly's Cymbalta for chronic low back pain treatment

Zimmer launches UniWallis Posterior Dynamic Stabilization System in Europe and Asia Pacific

Patients of orthopedists are more apt to undergo back surgery

SI-BONE receives FDA approval for updated iFuse Implant System

Physiotherapy Associates inaugurates new clinic in Grand Haven, MI

Acorda receives patent for AMPYRA tablets to improve walking in MS patients

Patients with low back pain can benefit from immediate physiotherapy

Chicago doctor develops new non-surgical procedure to alleviate back pain

Positive results from laquinimod Phase III ALLEGRO study in multiple sclerosis to be presented at AAN

Top-line results from DURECT's ELADUR Phase II trial in chronic low back pain

Gilenya can reduce risk of disability progression in patients with RRMS

Alexion submits Soliris marketing applications to FDA, EMA for aHUS treatment

Teenagers with scoliosis can benefit from new generation spine implants

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Important updates on spondyloarthritis highlighted at 2010 SPARTAN meeting

Pregnant women can benefit from low-to-moderate intensity weight-training program

Purdue demonstrates efficacy of Butrans transdermal delivery system for chronic pain in opioid-naive patients

Patients with low back pain can benefit from new spinal neuromodulation device

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Back Pain News and Research

Latest Back Pain News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in